Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Bimatoprost 0.01% vs Travoprost/Timolol in Glaucoma or Ocular Hypertension
NCT01881126Phase 4Completed
- Sponsor
- Allergan
- Start
- Jun 2013
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bimatoprost in Glaucoma, ocular hypertension, sponsored by Allergan. Started Jun 2013; status: completed.
02
Drugs
bimatoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT01881126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01881126.